CDNA logo

CDNA
Caredx Inc

3,213
Mkt Cap
$1.1B
Volume
1.39M
52W High
$23.24
52W Low
$10.96
PE Ratio
-54.32
CDNA Fundamentals
Price
$21.42
Prev Close
$22.42
Open
$22.97
50D MA
$18.29
Beta
1.51
Avg. Volume
616,740.93
EPS (Annual)
-$0.4007
P/B
3.60
Rev/Employee
$496,477.12
$852.92
Loading...
Loading...
News
all
press releases
All You Need to Know About CareDx (CDNA) Rating Upgrade to Buy
CareDx (CDNA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·3d ago
News Placeholder
More News
News Placeholder
Are Medical Stocks Lagging CareCloud (CCLD) This Year?
Here is how CareCloud, Inc. (CCLD) and CareDx (CDNA) have performed compared to their sector so far this year.
Zacks·3d ago
News Placeholder
Sumitomo Mitsui Trust Group Inc. Trims Stake in CareDx, Inc. $CDNA
Sumitomo Mitsui Trust Group Inc. lowered its holdings in CareDx, Inc. (NASDAQ:CDNA - Free Report) by 16.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,446,616 shares of the company's stock after selling 293,448 s...
MarketBeat·3d ago
News Placeholder
CareDx Sharpens Focus On Core Testing Services
CareDx Inc. (CDNA) sells Lab Products business to EuroBio Scientific for $170 million in cash, focusing on higher-growth precision testing and digital solutions.read more...
Benzinga·4d ago
News Placeholder
CareDx (NASDAQ:CDNA) Reaches New 1-Year High - Here's Why
CareDx (NASDAQ:CDNA) Reaches New 1-Year High - Time to Buy...
MarketBeat·4d ago
News Placeholder
Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 15.6% following a $41M production order from an AI customer. Other big gainers include Xanadu...
Benzinga·4d ago
News Placeholder
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue healthcare solutions for transplant patients and caregivers, today announced that it has entered into a...
Business Wire·5d ago
News Placeholder
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·6d ago
News Placeholder
CareDx (NASDAQ:CDNA) Shares Down 7.9% - What's Next?
CareDx (NASDAQ:CDNA) Shares Down 7.9% - Should You Sell...
MarketBeat·11d ago
News Placeholder
345,308 Shares in CareDx, Inc. $CDNA Purchased by Aberdeen Group plc
Aberdeen Group plc acquired a new position in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·11d ago
<
1
2
...
>

Latest CDNA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.